Astrana Health Company Top Insiders
| ASTH Stock | 24.23 0.05 0.21% |
Under 57% of all Astrana Health's insiders are taking a long position. The analysis of insiders' sentiment of trading Astrana Health stock suggests that some insiders are bullish at this time. Astrana Health employs about 3 K people. The company is managed by 23 executives with a total tenure of roughly 7000 years.
Insider Sentiment
Mostly Buying
Selling | Buying |
Latest Trades
| 2024-01-10 | Judy Chu | Acquired @ 37.66 | |||
| 2022-06-17 | Linda Marsh | Disposed 250000 @ 37 | View | ||
| 2021-08-17 | Physicians Of Californi Allied | Acquired 40000 @ 73.67 | View | ||
| 2021-06-15 | Albert Waichow Young | Disposed 5000 @ 48.58 | View | ||
| 2021-05-13 | Brandon Sim | Acquired 1000 @ 31.4 | View | ||
| 2021-04-28 | Physicians Of Californi Allied | Acquired 100000 @ 24.5 | View | ||
| 2021-04-01 | Physicians Of Californi Allied | Disposed 1638045 @ 24.5 | View |
Following insider trading sentiment in Astrana Health can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. This data should be handled carefully because insiders are required to disclose trades publicly and the motives behind a trade are not always purely directional.
Acquired vs Disposed
Filed vs Not Filed
For Astrana Health, insider trading sentiment is often gauged by the transaction pattern of people closest to the business, including officers, directors, and large holders. Used properly, insider trading data is contextual rather than absolute because corporate insiders can transact for several reasons that are not purely directional.
Management Team Effectiveness
The company has return on total asset (ROA) of 3.43 % suggesting that asset deployment is earning returns that cover operational costs. This is neither notably high nor low for the sector. Similarly, it shows a return on stockholder's equity (ROE) of 4.49 %, suggesting that shareholder investment generated $4.49 per $100 in returns.Per market data dated March 23, 2026, Common Stock Shares Outstanding is projected to grow to approximately 51.8 M. Also, Net Income Applicable To Common Shares is projected to grow to approximately 59.2 M.
Stock Institutional Investors
About 60.65% of Astrana Health is held by institutions, with insiders at 22.41%. Current market capitalization is about 1.35 Billion. This helps separate index flows from active bets. Shares outstanding are near 55.6 M. The insider stake is large enough to signal management alignment, which can steady the price during sell-offs.
| Shares | Jacobs Levy Equity Management, Inc. | 2025-12-31 | 473.7 K | Northcrest Asset Management, Llc | 2025-12-31 | 450.5 K | Ameriprise Financial Inc | 2025-09-30 | 442.3 K | Diamond Hill Capital Management Inc | 2025-12-31 | 432.7 K | Northern Trust Corp | 2025-09-30 | 423.2 K | Hotchkis & Wiley Capital Management Llc | 2025-12-31 | 416.9 K | Royce & Associates, Lp | 2025-12-31 | 348.3 K | The Goldman Sachs Group Inc | 2025-09-30 | 317 K | Lpl Financial Corp | 2025-12-31 | 309.1 K | Blackrock Inc | 2025-09-30 | 6 M | Vanguard Group Inc | 2025-12-31 | 4.2 M |
Insider Trading Activities
Insider disclosures for Astrana Health show how people closest to the business are behaving as market expectations change. Current market capitalization is about 1.35 Billion. These records work best as context, not as standalone buy-or-sell signals.
Outstanding Bonds
Corporate bonds issued by Astrana Health matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| US03765HAB78 Corp BondUS03765HAB78 | View | |
| US03765HAD35 Corp BondUS03765HAD35 | View | |
| US03765HAF82 Corp BondUS03765HAF82 | View | |
| US03762UAD72 Corp BondUS03762UAD72 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Corporate Filings
10K | 12th of March 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 9th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of March 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 2nd of March 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 30th of January 2026 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 27th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 15th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Shares in Circulation | First Issued 2001-09-30 | Previous Quarter 49.5 M | Current Value 49.5 M | Average Shares Outstanding 18.3 M | Quarterly Volatility 21.4 M |
Macro event markers
Holders Distribution
A large institutional presence around Astrana Health deserves attention because well-resourced investors can establish or unwind positions quickly enough to change the market character of the security. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.
Market Cap and Value
Workforce Comparison
Astrana Health is rated below average for number of employees among direct rivals. The total workforce of Health Care industry is presently estimated at about 131,643. Astrana Health holds roughly 3,000 in number of employees claiming about 2.28% of equities under Health Care sector.
Profit Margins
The company has Profit Margin (PM) of 1.0 %, which implies limited profitability that leaves the business exposed to cost shocks. This is below expected levels for the industry. Similarly, it shows Operating Margin (OM) of 2.0 %, which entails that for every 100 dollars of sales, the company generated a net operating income of $2.0.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0883 | 0.093 |
|
|
Insider Trading History
The insider trade history for Astrana Health reveals whether executives were buying or selling during key price moves. Sustained buying at different price levels is a stronger signal than routine scheduled sales under 10b5-1 plans.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 0.4 | 2 | 5 | 41,334 | 61,464 |
| 2025-12-01 | 0.625 | 5 | 8 | 111,004 | 149,882 |
| 2025-09-01 | 0.3 | 3 | 10 | 48,000 | 103,717 |
| 2025-06-01 | 1.2 | 6 | 5 | 38,694 | 16,596 |
| 2025-03-01 | 0.7778 | 7 | 9 | 266,209 | 2,530,761 |
| 2024-12-01 | 1.0 | 10 | 10 | 390,104 | 44,328 |
| 2024-09-01 | 0.8571 | 12 | 14 | 96,839 | 112,716 |
| 2024-06-01 | 0.6667 | 2 | 3 | 101,997 | 15,680 |
Notable Stakeholders
Stakeholder analysis for Astrana Health is useful because companies often face trade-offs among groups that want very different outcomes from the same business. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Brandon Sim | President CEO | Profile | |
| Brandon MS | President CEO | Profile | |
| Kenneth MD | Executive Chairman | Profile | |
| MD FACS | CoFounder Chairman | Profile | |
| MPH MD | CoFounder Chairman | Profile | |
| Neil Ahuja | President Solutions | Profile | |
| Jaime MBA | President Texas | Profile | |
| Chandan Basho | CFO COO | Profile | |
| Chandan MBA | CFO COO | Profile | |
| Edgar Garrobo | VP CISO | Profile | |
| WaiChow MD | Chief Officer | Profile | |
| Rita Pew | Vice Operations | Profile | |
| Carlos MD | Chief Texas | Profile | |
| Glenn Sobotka | Chief Officer | Profile | |
| CPA CGMA | Chief Officer | Profile | |
| Jeremy MD | Chief Officer | Profile | |
| Boon Chen | Senior Engineering | Profile | |
| Yubin Park | Chief Officer | Profile | |
| Dinesh MD | Chief Officer | Profile | |
| John Vong | Chief Officer | Profile | |
| Shawn Arnone | Managing Group | Profile | |
| Rita MBA | Vice Operations | Profile | |
| Paul MBA | Senior Contracting | Profile |
Management Information & Data Sources
Astrana Health is a small-cap company in Health Care Providers & Services, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Management quality is often reflected indirectly through margin durability, reinvestment choices, and governance signals. CEO is Brandon Sim with 3,000 employees and 23 reported executives.
Unless otherwise specified, data for Astrana Health is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce efficiency at Astrana Health can help investors judge how effectively labor resources are being converted into revenue and profit over time. The business is commonly classified in the Health Care sector and the Health Care Equipment & Services industry.
Astrana Health Manpower Efficiency
Return on Astrana Health Manpower
| Revenue Per Employee | 1.1M | |
| Revenue Per Executive | 138.3M | |
| Net Income Per Employee | 8K | |
| Net Income Per Executive | 1M | |
| Working Capital Per Employee | 82.7K | |
| Working Capital Per Executive | 10.8M |
Popular Tools for Astrana Stock analysis
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |